Experiment 255533

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED

Compounds isolated

TEREBINTHACOSIDE III

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.VS.DMBA-INDUCED CARCINOGENESIS.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
CARCINOGENESIS INHIBITION
Administration routeEXTERNAL
OrganismAngelica furcijuga (APIACEAE)
CitationYAMAHARA,J:. (1999). NEW LIGNAN GLUCOSIDE, TEREBINTHACOSIDE III, AND ITS USE AS ANTITUMOR AGENT.. ()
Amount utilized
Compound isolated
Number2
Qualitative resultACTIVE
AnimalMOUSE
Dose expressionCONC USED